CLNN
Price:
$5.84
Market Cap:
$60.20M
Clene Inc. is a biopharmaceutical firm in the clinical development phase, dedicated to the discovery, advancement, and market introduction of pioneering therapeutic agents utilizing clean-surfaced nanotechnology (CSN). CNM-Au8 stands as its flagship compound, currently under evaluation across a diverse range of clinical studies. This includes a pivotal Phase 2/3 study intended for regulatory submission in individuals battling amyotrophic lateral sclerosis (ALS). The company has successfully concluded a Phase 2 proof-of-concept trial for those with early manifestations of ALS. Furthermore, two open-label, investigator-blinded Phase 2 trials assessing brain energy metabolism have been finished...[Read more]
Industry
Biotechnology
IPO Date
2018-10-18
Stock Exchange
NASDAQ
Ticker
CLNN
According to Clene Inc.’s latest financial reports and current stock price. The company's current ROE is 233.93%. This represents a change of 269.45% compared to the average of 63.32% of the last 4 quarters.
The mean historical ROE of Clene Inc. over the last ten years is -751.87%. The current 233.93% ROE has changed -131.11% with respect to the historical average. Over the past ten years (40 quarters), CLNN's ROE was at its highest in in the June 2024 quarter at 1.35%. The ROE was at its lowest in in the March 2022 quarter at -662.07%.
Average
-751.87%
Median
-77.32%
Minimum
-5653.08%
Maximum
444.85%
Discovering the peaks and valleys of Clene Inc. ROE, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 5.86%
Maximum Annual ROE = 444.85%
Minimum Annual Increase = -Infinity%
Minimum Annual ROE = -5653.08%
| Year | ROE | Change |
|---|---|---|
| 2025 | 148.78% | -66.56% |
| 2024 | 444.85% | -220.32% |
| 2023 | -369.71% | -60.00% |
| 2022 | -924.25% | 1.10% |
| 2021 | -77.32% | -98.63% |
| 2020 | -5653.08% | 1.61% |
| 2019 | -330.57% | 5.86% |
| 2018 | -5.55% | -Infinity% |
The current ROE of Clene Inc. (CLNN) is less than than its 3-year, greater than its 5-year, and greater than its 10-year historical averages
3-year avg
74.64%
5-year avg
-155.53%
10-year avg
-751.87%
Clene Inc.’s ROE is greater than MacroGenics, Inc. (-147.80%), greater than Ovid Therapeutics Inc. (-22.51%), greater than Coya Therapeutics, Inc. (-57.26%), less than Oramed Pharmaceuticals Inc. (55.29%), greater than Whitehawk Therapeutics Inc (-79.63%), greater than Context Therapeutics Inc. (-59.95%), greater than Zentalis Pharmaceuticals, Inc. (-53.61%), greater than Shattuck Labs, Inc. (-60.73%), greater than Pliant Therapeutics, Inc. (-59.06%), greater than Connect Biopharma Holdings Limited (-49.43%),
| Company | ROE | Market cap |
|---|---|---|
| -147.80% | $251.71M | |
| -22.51% | $303.33M | |
| -57.26% | $86.31M | |
| 55.29% | $158.38M | |
| -79.63% | $205.72M | |
| -59.95% | $127.71M | |
| -53.61% | $266.95M | |
| -60.73% | $236.64M | |
| -59.06% | $69.97M | |
| -49.43% | $133.48M |
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Clene Inc. using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like Clene Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the ROE?
How can you use the ROE?
What is Clene Inc.'s ROE?
How is the ROE calculated for Clene Inc. (CLNN)?
What is the highest ROE for Clene Inc. (CLNN)?
What is the 3-year average ROE for Clene Inc. (CLNN)?
What is the 5-year average ROE for Clene Inc. (CLNN)?
How does the current ROE for Clene Inc. (CLNN) compare to its historical average?